RNF40-dependent epigenetic regulation of actin cytoskeletal dynamics is required for HER2-driven mammary tumorigenesis

The HER2-driven breast cancer subtype displays a particularly aggressive behavior. Alterations of the epigenome are common in cancers and represent attractive novel molecular therapeutic targets. Monoubiquitination of histone 2B (H2Bub1) by its obligate heterodimeric E3 ubiquitin ligase complex RNF20/RNF40 has been described to have tumor suppressor functions and loss of H2Bub1 has been associated with cancer progression. In this study, we utilized human tumor samples, cell culture models, and a mammary carcinoma mouse model with tissue-specific Rnf40 deletion and identified an unexpected tumor-supportive role of RNF40 in HER2-positive breast cancer. We demonstrate that RNF40-driven H2B monoubiquitination is essential for transcriptional activation of RHO/ROCK/LIMK pathway components and proper actin cytoskeleton dynamics through a trans-histone crosstalk with histone 3 lysine 4 trimethylation (H3K4me3). Collectively, this work demonstrates a previously unknown essential role of RNF40 in HER2-positive breast cancer, revealing the RNF20/RNF40/H2Bub1 axis as a possible tumor context-dependent therapeutic target in breast cancer. Statement of significance HER2-positive breast cancer patients frequently develop resistance to anti-HER2 therapies. Here we demonstrate that RNF20/RNF40-mediated H2B monoubiquitination supports the oncogenic properties of cancer cells of this subtype by regulating actin dynamics. The RNF20/RNF40/H2Bub1 axis may therefore represent an attractive drug target for novel therapies.

[1]  J. Hartman,et al.  PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer , 2019, Nature Communications.

[2]  R. Chua,et al.  The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells , 2019, Clinical Epigenetics.

[3]  O. Barbash,et al.  Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer , 2019, Nature Medicine.

[4]  J. Armache,et al.  Structural Basis of Dot1L Stimulation by Histone H2B Lysine 120 Ubiquitination. , 2019, Molecular cell.

[5]  S. Johnsen,et al.  DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network , 2018, Proceedings of the National Academy of Sciences.

[6]  A. Craig,et al.  Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis , 2018, Scientific Reports.

[7]  H. Schildhaus,et al.  Loss of RNF40 Decreases NF-&kgr;B Activity in Colorectal Cancer Cells and Reduces Colitis Burden in Mice , 2018, Journal of Crohn's & colitis.

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  Wei Li,et al.  Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis , 2018, Genome research.

[10]  Jinhui Wang,et al.  Loss of H2B monoubiquitination is associated with poor‐differentiation and enhanced malignancy of lung adenocarcinoma , 2017, International journal of cancer.

[11]  André F. Vieira,et al.  Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells , 2017, Nature Communications.

[12]  S. Bonn,et al.  RNF40 regulates gene expression in an epigenetic context-dependent manner , 2017, Genome Biology.

[13]  Y. Yarden,et al.  RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer , 2017, Cell Death and Differentiation.

[14]  Y. Shang,et al.  Corrigendum: Ubiquitin ligase RNF20/40 facilitates spindle assembly and promotes breast carcinogenesis through stabilizing motor protein Eg5 , 2016, Nature Communications.

[15]  C. Streuli,et al.  Oncogenic activation of FAK drives apoptosis suppression in a 3D-culture model of breast cancer initiation , 2016, Oncotarget.

[16]  Y. Shang,et al.  Ubiquitin ligase RNF20/40 facilitates spindle assembly and promotes breast carcinogenesis through stabilizing motor protein Eg5 , 2016, Nature Communications.

[17]  E. Tsai,et al.  Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling , 2016, Oncotarget.

[18]  Elisa de Stanchina,et al.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT , 2016, Cell.

[19]  Ron Rotkopf,et al.  RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer , 2016, Cell reports.

[20]  Xi Chen,et al.  Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes , 2015, Nature Genetics.

[21]  G. Ast,et al.  Cotranscriptional histone H2B monoubiquitylation is tightly coupled with RNA polymerase II elongation rate , 2014, Genome research.

[22]  Y. Yung,et al.  LPA receptor signaling: pharmacology, physiology, and pathophysiology , 2014, Journal of Lipid Research.

[23]  J. Rüschoff,et al.  SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms , 2014, Oncogene.

[24]  Y. Liu,et al.  Cadmium affects focal adhesion kinase (FAK) in mesangial cells: Involvement of CaMK‐II and the actin cytoskeleton , 2013, Journal of cellular biochemistry.

[25]  Ying Sun,et al.  RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. , 2012, Cancer research.

[26]  Su Chen,et al.  Histone H2B lysine 120 monoubiquitination is required for embryonic stem cell differentiation , 2012, Cell Research.

[27]  T. Beißbarth,et al.  The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells. , 2012, Molecular cell.

[28]  E. Domany,et al.  RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. , 2012, Molecular cell.

[29]  S. Johnsen.  The enigmatic role of H2Bub1 in cancer , 2012, FEBS letters.

[30]  M. Desouza,et al.  The actin cytoskeleton as a sensor and mediator of apoptosis , 2012, Bioarchitecture.

[31]  J. Brooks,et al.  Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. , 2012, Cancer research.

[32]  Y. Mo,et al.  Abstract 5025: Regulation of miR-145 expression by Foxo3a, C/EBP-β and p53 in cancer cells , 2012 .

[33]  T. Visakorpi,et al.  Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth , 2012, Molecular and Cellular Endocrinology.

[34]  J. Malaterre,et al.  MYB is essential for mammary tumorigenesis. , 2011, Cancer research.

[35]  S. Oesterreich,et al.  Epigenetics in breast cancer: what's new? , 2011, Breast Cancer Research.

[36]  H. Neumann,et al.  The H2B ubiquitin ligase RNF40 cooperates with SUPT16H to induce dynamic changes in chromatin structure during DNA double-strand break repair , 2011, Cell cycle.

[37]  T. Beißbarth,et al.  Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. , 2011, Cancer research.

[38]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[39]  S. Johnsen,et al.  Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing , 2009, Cell cycle.

[40]  M. Oren,et al.  CDK9 directs H2B monoubiquitination and controls replication‐dependent histone mRNA 3′‐end processing , 2009, EMBO reports.

[41]  A. Shilatifard,et al.  RAD6-Mediated Transcription-Coupled H2B Ubiquitylation Directly Stimulates H3K4 Methylation in Human Cells , 2009, Cell.

[42]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[43]  Eran Segal,et al.  Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells , 2008, Nature Cell Biology.

[44]  P. Bruni,et al.  Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response. , 2006, Biochimica et biophysica acta.

[45]  D. Reinberg,et al.  Histone H2B Monoubiquitination Functions Cooperatively with FACT to Regulate Elongation by RNA Polymerase II , 2006, Cell.

[46]  G. Hortobagyi,et al.  Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer , 2006, Nature Clinical Practice Oncology.

[47]  R. Roeder,et al.  The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions. , 2005, Molecular cell.

[48]  Kevin Struhl,et al.  Ubiquitination of Histone H2B by Rad6 Is Required for Efficient Dot1-mediated Methylation of Histone H3 Lysine 79* , 2002, The Journal of Biological Chemistry.

[49]  Zu-Wen Sun,et al.  Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast , 2002, Nature.

[50]  P. Hussey,et al.  The ADF/cofilin family: actin-remodeling proteins , 2002, Genome Biology.

[51]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[52]  K. Burridge,et al.  Rho-stimulated contractility drives the formation of stress fibers and focal adhesions , 1996, The Journal of cell biology.

[53]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  N. Brockdorff,et al.  The interplay of histone modifications – writers that read , 2015, EMBO reports.